Search Results - "Sobieszczyk, M. E."

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections by Sobieszczyk, Magdalena E., Furuya, E. Yoko, Hay, Christine M., Pancholi, Preeti, Della-Latta, Phyllis, Hammer, Scott M., Kubin, Christine J.

“…Background: The treatment of infections caused by multidrug-resistant (MDR) Gram-negative organisms poses a therapeutic challenge. The use of polymyxin B has…”
Get full text

Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru by Shu, E., Sobieszczyk, M. E., Sal y Rosas, V. G., Segura, P., Galea, J. T., Lecca, L., Sanchez, J., Lama, J. R.

“…SETTING: A safe, effective vaccine would improve tuberculosis (TB) control worldwide. Extensive community engagement will be essential to ensure the interest…”
Get full text

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition by Corey, Lawrence, Gilbert, Peter B, Juraska, Michal, Montefiori, David C, Morris, Lynn, Karuna, Shelly T, Edupuganti, Srilatha, Mgodi, Nyaradzo M, deCamp, Allan C, Rudnicki, Erika, Huang, Yunda, Gonzales, Pedro, Cabello, Robinson, Orrell, Catherine, Lama, Javier R, Laher, Fatima, Lazarus, Erica M, Sanchez, Jorge, Frank, Ian, Hinojosa, Juan, Sobieszczyk, Magdalena E, Marshall, Kyle E, Mukwekwerere, Pamela G, Makhema, Joseph, Baden, Lindsey R, Mullins, James I, Williamson, Carolyn, Hural, John, McElrath, M. Juliana, Bentley, Carter, Takuva, Simbarashe, Gomez Lorenzo, Margarita M, Burns, David N, Espy, Nicole, Randhawa, April K, Kochar, Nidhi, Piwowar-Manning, Estelle, Donnell, Deborah J, Sista, Nirupama, Andrew, Philip, Kublin, James G, Gray, Glenda, Ledgerwood, Julie E, Mascola, John R, Cohen, Myron S

“…Two phase 2 trials assessed the efficacy and safety of intravenous infusions of a broadly neutralizing antibody, VRCO1, to prevent HIV-1 infection. VRC01 did…”
Get full text

Prevalence and Predictors of Metabolic Syndrome Among HIV-Infected and HIV-Uninfected Women in the Women's Interagency HIV Study by SOBIESZCZYK, Magdalena E, HOOVER, Donald R, PLANKEY, Michael W, LEVINE, Alexandra M, JUSTMAN, Jessica, ANASTOS, Kathryn, MULLIGAN, Kathleen, TAN, Tianren, QIUHU SHI, WEI GAO, HYMAN, Charles, COHEN, Mardge H, COLE, Stephen R

“…To assess the prevalence of metabolic syndrome (MetSynd) among participants of the Women's Interagency HIV Study and to describe the association of MetSynd…”
Get full text

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial by Markowitz, Martin, Prof, Frank, Ian, Prof, Grant, Robert M, Prof, Mayer, Kenneth H, Prof, Elion, Richard, MD, Goldstein, Deborah, MD, Fisher, Chester, MD, Sobieszczyk, Magdalena E, MD, Gallant, Joel E, MD, Van Tieu, Hong, MD, Weinberg, Winkler, MD, Margolis, David A, MD, Hudson, Krischan J, PhD, Stancil, Britt S, BS, Ford, Susan L, Pharm D, Patel, Parul, Pharm D, Gould, Elizabeth, BS, Rinehart, Alex R, PhD, Smith, Kimberly Y, MD, Spreen, William R, Pharm D

“…Summary Background Cabotegravir (GSK1265744) is an HIV-1 integrase strand transfer inhibitor with potent antiviral activity and a long half-life when…”
Get full text

Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies by ETTER, Paige, LANDOVITZ, Raphael, SIBEKO, Sengeziwe, SOBIESZCZYK, Magdalena E, RIDDLER, Sharon A, KARG, Carissa, TSIBRIS, Athe, SCHOUTEN, Jeffrey

“…To facilitate collection of cumulative data on longitudinal HIV disease outcomes during HIV prevention studies by developing recommendations for follow-up of…”
Get full text

Engaging Members of African American and Latino Communities in Preventive HIV Vaccine Trials by Sobieszczyk, Magdalena E, Xu, Guozhen, Goodman, Krista, Lucy, Debbie, Koblin, Beryl A

“…BACKGROUND:African Americans (AAs) and Latinos in United States bear a disproportionate burden of HIV infection, yet remain underrepresented in HIV vaccine…”
Get full text

Prevalence and Predictors of Metabolic Syndrome Among HIV-lnfected and HIV-Uninfected Women in the Women's Interagency HIV Study by Sobieszczyk, ME, Hoover, DR, Anastos, K, Mulligan, K, Tan, T, Shi, Q, Gao, W, Hyman, C, Cohen, M H, Cole, SR, Plankey, M W, Levlne, A M, Justman, J

“…Objectives: To assess the prevalence of metabolic syndrome (MetSynd) among participants of the Women's Interagency HIV Study and to describe the association of…”
Get full text